SunTrust Downgrades Zafgen (ZFGN) to Neutral
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/2/2026
- Wall St ends higher as stocks reclaim some shine
- Broadcom raises AI chip forecast as Big Tech keeps writing bigger checks
- Snowflake soars 20% on earnings beat and raised guidance
- Oil settles 1% higher, as US-Iran strikes threaten supplies
- Could Apple’s foldable iPhone be a $14B opportunity? Morgan Stanley weighs in
- GoPro to merge with Starman Optical in $285M recapitalization deal
- GoPro (GPRO) Halted, News Pending
- Crude Inventory Fell 4.5M Barrels Last Week - EIA
- Wall Street ends lower as higher yields, rising oil prices mark shaky start to September
- TScan cuts 75% of workforce, pivots to solid tumor cell therapy
Leerink Partners Downgrades Zafgen (ZFGN) to Market Perform
December 3, 2015 11:02 AM ESTLeerink Partners downgraded Zafgen (NASDAQ: ZFGN) from Outperform to Market Perform with a price target of $7.00 (from $11.00) after further lowering probability of success for beloranib to 30% (from 40% previously) in our SOTP DCF analysis since the threshold for justifying risk-benefit has considerably been increased w/... More
